Know what
you are buying.
Useful questions before a study, a software pilot or a license. Each guide connects a decision framework to a tool, a scope and its source trail.
Read with a next step.
What does a cellular senescence study cost?
Compare published assay cost anchors with the complete scope of a cellular senescence research study: controls, repeats, analysis and data rights.
How to scope an aging-biomarker research study
Define a research question, model, endpoints, quality controls and data handover before commissioning a cellular-aging study.
CRISPR screen analysis: a buyer’s review checklist
A nonclinical scoping checklist for CRISPR screen provenance, data QC, hit robustness, confounders and independent follow-up evidence.
Biotech licensing due diligence: from listing to decision
Separate scientific evidence, asset availability, development cost, patent questions and commercial-use rights when evaluating a research technology.
Research biomarkers are not automatically clinical tests
Understand why research-use labels, molecular-age changes and preclinical findings do not automatically establish clinical utility or consumer claims.
How to compare biotech research-service proposals
Compare evidence reviews, data analysis and outsourced study proposals using scope, reviewer qualifications, acceptance criteria and usable rights.
Biotech research funding readiness checklist
Prepare a technical question, eligible entity, qualified team, data rights, registrations, budget and milestones before pursuing a biotech R&D application.
Follow the commercial evidence.
Bring us the decision.
Describe a nonconfidential question, a deadline and what a useful answer would change. We will assess fit, qualifications and delivery capacity before proposing an engagement.
Bring a defined need or a demonstrated capability.
The CRISPR section connects target assessment, study scoping and data-review questions with proposed discovery programs. Start with a nonconfidential decision or a specific scientific capability; no institution is assumed to be an existing partner.
Explore services and programs